跳至主要内容
临床试验/NCT05292534
NCT05292534已完成不适用

Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.

Sonova AG2 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2022年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Sonova AG
入组人数
38
试验地点
2
主要终点
Tinnitus Functional Index Evaluation (TFI)

研究概览

简要总结

Participants with hearing loss and Tinnitus will wear hearing aids with amplification-only or with an added sound, and have their tinnitus level evaluated before and after intervention.

详细描述

2 groups of adults with hearing loss and chronic bothersome tinnitus and no experience with amplification will participate in a cross over intervention study with 2 conditions of 4 weeks each: 1. fit with hearing aid (HA) amplification-only, and 2. fit with HA amplification with an added sound, returning to their original unaided condition after undergoing the intervention phase.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hearing loss
  • candidate for hearing aid amplification
  • Bothersome chronic tinnitus (3 months+)

排除标准

  • age less than 18 years
  • normal hearing
  • tinnitus presence for less than 3 months
  • tinnitus not bothersome enough to warrant intervention
  • non hearing aid candidates

结局指标

主要结局

Tinnitus Functional Index Evaluation (TFI)

时间窗: TFI collected before intervention to serve as a baseline. TFI change from baseline will be assessed after each study condition, which will last 4 weeks/each.

Tinnitus Functional Index (TFI) questionnaire results, ranging from 0 to 100, with higher numbers indicating more severe (worse) Tinnitus interference in the person's quality of life.

次要结局

未报告次要终点

研究者

发起方
Sonova AG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验